CTRI/2012/05/002696已完成3 期
niform Multi Drug Therapy regimen for all leprosy patients
WHOTDR0 个研究点目标入组 3,500 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 3,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All the newly detected and treatment-naive leprosy patients will be eligible for inclusion. It is suggested the following categories of patients may be included in the study: easily accessible to the clinic, available for long-term follow-up and for receiving supervised dose of drug.
排除标准
- •Newly detected pure neuritic patients, old patients, who are already receiving PB or MB-MDT, returned defaulters, and those who relapse subsequent to the earlier therapy will not be eligible for inclusion for this study.
研究者
相似试验
招募中
4 期
Evaluation of the effectiveness of the use of rifampicin to prevent leprosy in contacts of patients with multibacillary formeprosy, chemoprevention, clinical trial, rifampicin.E02.319.162V03.175.250D03.633.400.811.700RBR-69qk5pInstituto Oswaldo Cruz - Laboratório de Hanseníase
招募中
4 期
Treatment of Early Neuropathy in LeprosyCTRI/2011/09/002022Royal Tropical Institute KIT790
已完成
4 期
Treatment of Early Neuropathy in LeprosyCTRI/2011/09/002023Royal Tropical Institute KIT655
招募中
不适用
Leptospirosis Care Bundle StudyLeptospirosisNCT05425524Chulalongkorn University300
招募中
Unknown
PEP4LEP - Chemoprophylaxis for leprosy: comparing the effectiveness and feasibility of a skin camp intervention to a health centre-based interventioleprosy, and other skin diseases including skin NTDsSkin and Connective Tissue DiseasesPACTR202303742093429R30,000